News by topic

Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Resistance news

Show

From To
Resistance
Transmitted drug resistance now less likely to harm HIV treatment options, US study finds

The rising prevalence of transmitted antiretroviral drug resistance in the United States is unlikely to affect the success of first-line treatment in the future and

Published
19 June 2018
By
Keith Alcorn
CD4 count
Low CD4 count in patients with HIV prolongs influenza viral shedding

HIV-infected individuals with a low CD4 count experienced a longer duration of influenza virus shedding, according to findings published in The Journal of Infectious Diseases.

Published
11 June 2018
From
Healio itj+ (requires free registration)
Epidemiology and behaviour
Computer Models Are Changing How We Craft HIV-AIDS Policies

A computer modeling of AIDS-affected populations of sub-Saharan Africa has recently enabled the World Health Organization (WHO) to identify a cost-effective measure to address the increasing prevalence of drug-resistant HIV in the region.

Published
04 May 2018
From
Healthcare Analytics News
Resistance
World Health Organization Debunks Reports of New HIV Strain

Respected world agencies are downplaying initial reports of a new strain of HIV found in the Philippines. The Joint United Nations Programme on HIV/AIDS (UNAIDS) and the World Health Organization (WHO) have both released statements that soundly reject recent initial media reports that warned their readers of a new, untreatable strain of HIV that has been identified in certain areas.

Published
13 April 2018
From
HIV Plus
Access to medicines and treatment
ARV stock-outs kill more Ugandans

“Of recent, HIV drug stock-out is adding a lot of misery to us as service providers in the ART clinics because we get very few drugs from National Medical Stores (NMS) which is not enough for our patients. We keep on begging for drugs from nearby health centres. When patients spend long time without taking drugs, they develop resistance,” Dr Peter Andrew Kalema said.

Published
12 April 2018
From
The Observer
PrEP
Reported PrEP 'Failure' Most Likely a Lack of Proper Testing and Adherence

When is a pre-exposure prophylaxis (PrEP) failure actually a provider failure? And how do we tell the difference? This was a question that came up at CROI 2018 after a poster presentation titled "Seroconversion on PrEP: A Protocol for Untangling Adherence versus Resistance Failure" sparked conversations and debates about how you distinguish an example of tenofovir/emtricitabine (Truvada) failing to protect an individual from acquiring HIV, versus a provider whose negligence and failure to follow Centers for Disease Control and Prevention (CDC) protocol may have put his or her patient at grave risk.

Published
21 March 2018
From
The Body PRO
Bad science and bogus treatments
Statement of UNAIDS on news reports of a new HIV strain in the Philippines

UNAIDS is concerned that media reports which make reference to HIV research in the Philippines are being interpreted as saying that there is a new and untreatable strain of the virus in the country. There is no new strain of HIV which has been found in the Philippines.

Published
21 March 2018
From
UNAIDS Asia-Pacific
Changing treatment
Failure of second-line ART is common in resource-limited countries, but modern third-line regimens work well

More than half of people in low- and middle-income countries may not maintain viral suppression on second-line antiretroviral therapy (ART), according to a study presented

Published
14 March 2018
By
Liz Highleyman
PrEP
Another possible case of PrEP 'breakthrough' infection reported

A presentation at the recent 25th Conference on Retroviruses and Opportunistic Infections (CROI 2018) describes what appears to be another case of infection with HIV in

Published
09 March 2018
By
Gus Cairns
PrEP
How much 'PrEP-resistant' HIV is out there?

A study presented at the recent 25th Conference on Retroviruses and Opportunistic Infections (CROI 2018) aims to quantify how many people with HIV there might be

Published
09 March 2018
By
Gus Cairns
← Prev12345...39Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.